Profiel
Liz Sands joined 3i in May 2008 to drive the Active Partnership programme through which she is assisting the leadership teams of companies within 3i’s portfolio to identify and realise their full potential.
She started her career at Natwest and from there joined AT Kearney’s Financial Institutions Group.
Liz then spent 12 years in professional services, where she successfully delivered multi-million-pound change programmes in both the private and public sectors.
Working at board level to build ambition and confidence, she drives change in a flexible and pragmatic way to ensure the realisation of value in fast paced and challenging environments.
Her success is due to her ability to connect with, motivate, excite and lead people.
She tackles challenges that cut across formal organisational structures and boundaries which require a practical, yet innovative approach.
She has a BSc and MSc in Chemistry from Kent University, where her work was industrially sponsored and subsequently patented.
She also has an MBA from Kingston University.
Eerdere bekende functies van Liz Sands
| Bedrijven | Functie | Einde |
|---|---|---|
3i Private Equity
3i Private Equity Investment ManagersFinance 3i Private Equity invests in middle market companies located in Europe and North America with an enterprise value of EUR 100 - 500 million. The firm target companies operating in the fields of consumer & private label, healthcare and industrial services & software sectors. It provides financing for buyout and growth stage capital requirements. The firm acquires majority and minority interests. It also makes co-investments. | Private Equity Investor | 06-07-2010 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
3i Private Equity
3i Private Equity Investment ManagersFinance 3i Private Equity invests in middle market companies located in Europe and North America with an enterprise value of EUR 100 - 500 million. The firm target companies operating in the fields of consumer & private label, healthcare and industrial services & software sectors. It provides financing for buyout and growth stage capital requirements. The firm acquires majority and minority interests. It also makes co-investments. | Finance |
















